It will be necessary to create infrastructure for vaccine production in Ukraine from scratch, while the state support program could contribute to this, Commercial Director of PJSC Borschahivsky Chemical and Pharmaceutical Plant Yevhen Sova believes. “Today it will be necessary to create infrastructure for vaccine production in Ukraine virtually from scratch. This is quite a long process, because we are talking about the construction of new workshops, the launch of additional production lines, passage of audits and confirmation of quality according to the standards,” he told Interfax-Ukraine.
At the same time, the expert noted that “Ukrainian pharmaceutical manufacturers can implement this.” “The technical equipment of domestic companies as a whole allows building new necessary infrastructure, paying special attention to the sites of quality control,” he said.
According to the expert, the state support program can become an impetus for domestic pharmaceutical producers and a signal for starting work on the organization of such production. “Such a program will contribute to the process as much as possible. It can include public-private partnership, tax-exempt status, simplified inspection procedures and other options, including subsidies,” he said.